Back to search
HR 8663 - 118

DETECT Fentanyl and Xylazine Act of 2024

Became Public Law No: 118-186.

Bill highlights

Votes, text signals, source context, and latest movement from this record.

Bill Text Stats

6
Analyzed sections
N/A
Detected dollar total
0
Tax signals
0
Deadlines

Signal counts

Tax density 0.0%
Spending density 0.0%
Statutory Reference 6
Benefits 2

Top agencies

N/A

Statutory references

6 USC 182 2
15 U.S.C. 9401 1
6 USC 101 1
6 U.S.C. 182 1
Public Law 118-186 1

House Votes

No House roll call votes have been linked to this bill yet.

Timeline

Dec 23, 2024

Presented to President.

Dec 23, 2024

Presented to President.

Dec 23, 2024

Signed by President.

Dec 23, 2024

Signed by President.

Dec 23, 2024

Became Public Law No: 118-186.

Dec 23, 2024

Became Public Law No: 118-186.

Dec 18, 2024

Mr. Green (TN) moved that the House suspend the rules and agree to the Senate amendments. (consideration: CR H7335-7337, H7340-7341)

Dec 18, 2024

DEBATE - The House proceeded with forty minutes of debate on the motion to suspend the rules and agree to the Senate amendments to H.R. 8663.

Dec 18, 2024

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the chair announced that further proceedings on the motion would be postponed.

Dec 18, 2024

Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendments Agreed to by the Yeas and Nays: (2/3 required): 404 - 1 (Roll no. 514). (text: CR H7335-7336)

Dec 18, 2024

On motion that the House suspend the rules and agree to the Senate amendments Agreed to by the Yeas and Nays: (2/3 required): 404 - 1 (Roll no. 514). (text: CR H7335-7336)

Dec 18, 2024

Motion to reconsider laid on the table Agreed to without objection.

Dec 13, 2024

Message on Senate action sent to the House.

Dec 12, 2024

Senate Committee on Homeland Security and Governmental Affairs discharged by Unanimous Consent.

Dec 12, 2024

Senate Committee on Homeland Security and Governmental Affairs discharged by Unanimous Consent.

Dec 12, 2024

Measure laid before Senate by unanimous consent. (consideration: CR S7041)

Dec 12, 2024

Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.

Dec 12, 2024

Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7041)

Sep 10, 2024

Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

Sep 9, 2024

Mr. Gimenez moved to suspend the rules and pass the bill.

Sep 9, 2024

Considered under suspension of the rules. (consideration: CR H5064-5065)

Sep 9, 2024

DEBATE - The House proceeded with forty minutes of debate on H.R. 8663.

Sep 9, 2024

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5064)

Sep 9, 2024

On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5064)

Sep 9, 2024

Motion to reconsider laid on the table Agreed to without objection.

Aug 23, 2024

Reported by the Committee on Homeland Security. H. Rept. 118-634.

Aug 23, 2024

Reported by the Committee on Homeland Security. H. Rept. 118-634.

Aug 23, 2024

Placed on the Union Calendar, Calendar No. 531.

Jun 12, 2024

Subcommittee on Emergency Management and Technology Discharged

Jun 12, 2024

Committee Consideration and Mark-up Session Held

Jun 12, 2024

Ordered to be Reported by Voice Vote.

Jun 7, 2024

Introduced in House

Jun 7, 2024

Introduced in House

Jun 7, 2024

Referred to the House Committee on Homeland Security.

Jun 7, 2024

Referred to the Subcommittee on Emergency Management and Technology.

Affected Sectors

How to read this

Sectors are deterministic matches from official Congress.gov data and cached bill text. They are source-derived signals, not conclusions about intent or economic effect.

Evidence matches count official fields, normalized subjects, cached text snippets, or extracted entities that matched the sector rules.

Impact is a bill-level rollup used for sorting and filtering. It is not an economic impact estimate.

Confidence is the strongest individual match score behind that sector.

Evidence snippets show why a sector matched and can repeat when Congress.gov repeats the same phrase across official fields.

Defense
21 evidence matches
Impact 100% Confidence 78%

Homeland Security and Governmental Affairs Committee Standing Senate

Homeland Security Committee Standing House

at the end and inserting ing the capacity to detect and identify drugs such as fentanyl and xylazine Section 302 of the Homeland Security Act of 2002 ( 6 U.S.C. 182 ) is amended— (1) in paragraph (13), by striking and at the end; (2) in par

Technology and data privacy
21 evidence matches
Impact 100% Confidence 84%

Advanced technology and technological innovations

Computers and information technology

15 U.S.C. 9401 gies that use machine learning or artificial intelligence (as defined in section 5002 of the National Artificial Intelligence Initiative Act of 2020 ( 15 U.S.C. 9401 )) and other techniques t

Healthcare
11 evidence matches
Impact 100% Confidence 80%

Drug trafficking and controlled substances

the end; (2) in paragraph (14), by striking the period at the end and inserting ing the capacity to detect and identify drugs such as fentanyl and xylazine Section 302 of the Homeland Security Act of 2002 ( 6 U.S.C. 182 ) is amended— (1) in

benefit le="-uslm-lc:emspace2" value="15" “(15) carrying out, in coordination with the Drug Enforcement Administration, research, development, testing, evaluation, and cost-benefit analyses to improve the safety, effectivenes

Telecom and broadband
3 evidence matches
Impact 98% Confidence 86%

Science, Technology, Communications

Science, Technology, Communications

DETECT Fentanyl and Xylazine Act of 2024 Became Public Law No: 118-186. Science, Technology, Communications

State and local government
8 evidence matches
Impact 91% Confidence 73%

research, development, testing, evaluation, and cost-benefit analysis priorities under such section 302(15) based on the latest available information, including the latest State and Territory Report on Enduring and Emerging Threats publishe

cience and Technology's research, development, testing, evaluation, and cost-benefit analysis priorities under such section 302(15) based on the latest available information, including the latest State and Territory Report on Enduring and E

research, development, testing, evaluation, and cost-benefit analysis priorities under such section 302(15) based on the latest available information, including the latest State and Territory Report on Enduring and Emerging Threats publishe

CBO Cost Estimates

Official Congressional Budget Office cost estimate links associated with this bill through Congress.gov records.

How to read this

CBO estimates are official source documents with their own assumptions, scope, and publication dates. They can score a bill, a version of a bill, or a broader legislative package.

LawLinter stores the source link from Congress.gov and does not replace the CBO document. Use these cards as pointers for source review, not as independent fiscal advice.

CBO context shows source-attributed Congressional Budget Office cost estimates linked from official Congress.gov bill records. It is research context only; read the official CBO source document for assumptions, scope, and dates.

Campaign Finance Context

Related FEC/OpenFEC campaign-finance records for lawmakers and candidates tied to this bill through source-attributed legislative relationships. These are not donations to the bill itself.

How to read this

Amounts shown here are campaign-finance totals for sponsor or cosponsor-linked candidates and their committees in the displayed FEC cycle.

They are not donations to this bill, spending on this bill, or proof that money influenced or caused sponsorship, cosponsorship, votes, or legislative outcomes.

If multiple linked lawmakers have FEC records, this section can show multiple candidate cards and separate sponsor/cosponsor rollups.

Campaign-finance context uses source-attributed FEC/OpenFEC records that are related or relevant to the displayed bill, lawmaker, candidate, committee, or legislative relationship through deterministic links. It is research context only, not proof of influence, causation, endorsement, or that money caused a sponsorship, vote, or legislative outcome.

No FEC/OpenFEC campaign-finance context is currently linked for this bill.

Lobbying Context

Related LDA.gov filings where public lobbying activity descriptions reference this bill. These records are source-attributed research context, not evidence of influence or causation.

How to read this

LDA filings are public lobbying disclosure records. LawLinter links them here only when the filing activity text contains an exact-looking reference to this bill.

A filing can mention many issues, clients, agencies, or bills. A match should be treated as a pointer for review, not as a conclusion about why legislation changed or how any lawmaker acted.

Lobbying context uses source-attributed LDA.gov records that appear related to this bill through bill references in public lobbying activity descriptions. It is research context only, not proof of influence, causation, endorsement, lobbying effectiveness, or legislative intent.

No LDA.gov lobbying disclosure context is currently linked for this bill.

Summary

49 Public Law Jan 6, 2025

Detection Equipment and Technology Evaluation to Counter the Threat of Fentanyl and Xylazine Act of 2024 or the DETECT Fentanyl and Xylazine Act of 2024 This act provides statutory authority for the Department of Homeland Security's Science and Technology Directorate to take certain actions to support the detection of drugs such as fentanyl and xylazine. Specifically, the act provides statutory authority for the directorate's research and development efforts to improve drug detection equipment and reference libraries for law enforcement agencies, including with respect to portable equipment, equipment that can analyze complex samples, and technology that uses artificial intelligence or other techniques to detect new substances. The act additionally requires the directorate to follow certain standards and rely on certain information from the National Institute of Standards and Technology and the Drug Enforcement Administration, respectively, regarding these efforts.

55 Passed Senate Dec 17, 2024

Detection Equipment and Technology Evaluation to Counter the Threat of Fentanyl and Xylazine Act of 2024 or the DETECT Fentanyl and Xylazine Act of 2024 This bill provides statutory authority for the Department of Homeland Security's Science and Technology Directorate to take certain actions to support the detection of drugs such as fentanyl and xylazine. Specifically, the bill provides statutory authority for the directorate's research and development efforts to improve drug detection equipment and reference libraries for law enforcement agencies, including with respect to portable equipment, equipment that can analyze complex samples, and technology that uses artificial intelligence or other techniques to detect new substances. The bill additionally requires the directorate to follow certain standards and rely on certain information from the National Institute of Standards and Technology and the Drug Enforcement Administration, respectively, regarding these efforts.

53 Passed House Sep 30, 2024

Detection Equipment and Technology Evaluation to Counter the Threat of Fentanyl and Xylazine Act of 2024 or the DETECT Fentanyl and Xylazine Act of 2024 This bill provides statutory authority for the Department of Homeland Security's Science and Technology Directorate to take certain actions to support the detection of drugs such as fentanyl and xylazine. Specifically, the bill provides statutory authority for the directorate's research and development efforts to improve drug detection equipment and reference libraries for law enforcement agencies, including with respect to portable equipment, equipment that can analyze complex samples, and technology that uses artificial intelligence or other techniques to detect new substances. The bill additionally requires the directorate to follow certain standards and rely on certain information from the National Institute of Standards and Technology and the Drug Enforcement Administration, respectively, regarding these efforts.

07 Reported to House Sep 11, 2024

Detection Equipment and Technology Evaluation to Counter the Threat of Fentanyl and Xylazine Act of 2024 or the DETECT Fentanyl and Xylazine Act of 2024 This bill provides statutory authority for the Department of Homeland Security's Science and Technology Directorate to take certain actions to support the detection of drugs such as fentanyl and xylazine. Specifically, the bill provides statutory authority for the directorate's research and development efforts to improve drug detection equipment and reference libraries for law enforcement agencies, including with respect to portable equipment, equipment that can analyze complex samples, and technology that uses artificial intelligence or other techniques to detect new substances. The bill additionally requires the directorate to follow certain standards and rely on certain information from the National Institute of Standards and Technology and the Drug Enforcement Administration, respectively, regarding these efforts.

00 Introduced in House Sep 11, 2024

Detection Equipment and Technology Evaluation to Counter the Threat of Fentanyl and Xylazine Act of 2024 or the DETECT Fentanyl and Xylazine Act of 2024 This bill provides statutory authority for the Department of Homeland Security's Science and Technology Directorate to take certain actions to support the detection of drugs such as fentanyl and xylazine. Specifically, the bill provides statutory authority for the directorate's research and development efforts to improve drug detection equipment and reference libraries for law enforcement agencies, including with respect to portable equipment, equipment that can analyze complex samples, and technology that uses artificial intelligence or other techniques to detect new substances. The bill additionally requires the directorate to follow certain standards and rely on certain information from the National Institute of Standards and Technology and the Drug Enforcement Administration, respectively, regarding these efforts.

Sponsors

LaLota, Nick
Sponsor

LaLota, Nick

Republican · NY-1 · L000598

Joined Jun 7, 2024
Website
N/A
Office
122 Cannon House Office Building

Amendments

2 amendments
118/samdt/3329 Dec 12, 2024

In the nature of a substitute.

Amendment SA 3329 agreed to in Senate by Unanimous Consent.

118/samdt/3330 Dec 12, 2024

To amend the title.

Amendment SA 3330 agreed to in Senate by Unanimous Consent.

Compiled bill record. Bill pages combine Congress.gov source payloads, normalized relationships, cached text analysis, vote links, and deterministic sector/signal extraction. This is not an official government record or legal advice; use the official source link when accuracy matters.